DS
Daiichi Sankyo
DSNKY·OTCTokyo JPFounded 200517,000 employees
Large CappharmaPublicOncologyCardiology
Platform: DXd ADC
Market Cap
$60B
All Drugs
11
Clinical Trials
19
Failed / Terminated
9
FDA Approved
1
Stock Price & Catalysts (DSNKY)
Loading DSNKY stock data...
Drug Pipeline (11 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Doxafotisoran | DSN-8142 | Phase 1 | 1 | Cl18.2 | ALLGBM | ||
| DSN-2247 | DSN-2247 | NDA/BLA | 2 | EZH2 | AsthmaMM | ||
| DSN-791 | DSN-791 | NDA/BLA | 1 | Aβ | ACCMS | ||
| Bemarelsin | DSN-5517 | Preclinical | 1 | GLP-1R | PV | ||
| DSN-3066 | DSN-3066 | Phase 3 | 4 | IL-13 | PsAPTSD | ||
| Pexaosocimab | DSN-5476 | Phase 2 | 2 | PD-1 | Cervical CaOvarian Ca | ||
| DSN-5254 | DSN-5254 | Phase 1 | 2 | B7-H3 | CKDHemophilia A | ||
| DSN-1421 | DSN-1421 | Phase 3 | 1 | Nectin-4 | PsAET | ||
| DSN-6862 | DSN-6862 | Preclinical | 1 | IL-23 | Pancreatic CaNSCLC | ||
| Pexamavacamten | DSN-728 | NDA/BLA | 2 | TIGIT | Heart Failure | ||
| DSN-7360 | DSN-7360 | Approved | 2 | SGLT2 | FL |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (21)